Artificial Intelligence

Optina's REPHRASE Study Validates Innovative Alzheimer's Test

Optina Diagnostics' pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of Alzheimer's Disease (AD). This landmark study is focused on validating the novel awAIr™-Cerebral Amyloid Status (CAS) test, an innovative tool intended to provide physicians with definitive information about Alzheimer's pathology, enabling improved management of cognitive impairments....

DiamiR Biosciences Partners with JADBio to Utilize Machine Learning in Assay Development

DiamiR Biosciences, a developer of innovative non-invasive blood-based diagnostic tests for brain health and other diseases, today announced that it has entered into an agreement with JADBio to utilize its Automated Machine Learning (AutoML) Platform and Services for development of predictive models based on DiamiR's microRNA panels and other factors for risk assessment in Alzheimer's disease and Rett syndrome....

CMS Introduces HCPCS Code for Ultromics EchoGo® Heart Failure, Enhancing HFpEF Detection Access

Ultromics, a leading health technology company advancing a novel approach for detecting heart failure and its phenotypes, announced today the assignment of a new outpatient code by the Centers for Medicare and Medicaid Services (CMS), for its flagship product, EchoGo® Heart Failure. HCPCS code C9786 can now be used for billing artificial intelligence to aid the detection of Heart Failure with Preserved Ejection Fraction (HFpEF). HCPCS code C9786 can now be used for billing artificial intell...

Abbott Receives FDA Approval for World's First Dual Chamber Leadless Pacemaker

Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR™ dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms. With more than 80% of people who need a pacemaker requiring pacing in two chambers of the heart (both the right atrium and right ventricle), the approval significantly increases access to leadless pacing for millions of people across the U.S.[i]...

AOI Revolutionizes Cancer Care in Telangana with AI-Powered Ethos Radiotherapy, Becomes Advanced Cancer Centre

Inaugurated by the Minister for Finance, Health, Medical & Family Welfare, Government of Telangana ...

Lunit's AI Solution Impacts Radiologists' Lung Cancer Diagnosis

Recent study conducted by Seoul National University Hospital provides strong evidence that high-accuracy AI model improves radiologists' chest X-ray analysis performance...

Kauvery Hospital, Chennai Introduces Next-Generation AI-Based Ultreon Coronary Imaging System

Kauvery Heart Institute, the center of excellence in comprehensive cardiac services at Kauvery Hospital - Radial Road, Kovilambakkam, proudly announces the launch of the latest AI-based Ultreon Coronary Imaging system. By acquiring this ground-breaking technology, Kauvery Hospital - Radial Road positions itself as the leader in Cardiac Sciences by being the first hospital in Tamil Nadu to acquire a state-of-the-art OCT system, empowering cardiologists with advanced capabilities for precise coron...

Koning Corporation Unveils Revolutionary AI-Enhanced Software to Boost Breast CT Image Quality

Koning Corporation, a global leader in breast computed tomography (CT) technology, is thrilled to announce the launch of its breakthrough Artificial Intelligence (AI) software, designed to enhance image quality significantly. The upgrade to their software system is set to provide unparalleled clarity in breast imaging, promising a game-changing impact on the early detection and treatment of breast cancer....